NCT04216719 |
|
Facilitating Opioid Care Connections
|
View
|
NCT05417425 |
|
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
|
View
|
NCT05739968 |
|
Impacts and Testing of the Multi-domains Active-living Program in Operable Non-Muscle Invasive Bladder Cancer Patients
|
View
|
NCT05921292 |
|
Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous WoundsUlcers of Multiple Etiologies
|
View
|
NCT01492634 |
|
Optimizing Fluid Status
|
View
|
NCT02678572 |
|
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
|
View
|
NCT05720702 |
|
A Feasibility Trial of OCM Supplements for the Treatment of NAFLD
|
View
|
NCT05022901 |
|
An Open-Label Expanded Access Study of the MelphalanHepatic Delivery System HDS in Patients With Hepatic Dominant Ocular Melanoma
|
View
|
NCT04063423 |
|
Non- Clinical Coagulation Activation During Hemodialysis
|
View
|